WELL HEALTH TECHNOLOGIES (WELL-DB.CA) Stock Overview
Canada - TSX:WELL-DB - CA94947LAC69
100.6 CAD
+0.1 (+0.1%)
Overall WELL-DB gets a fundamental rating of 3 out of 10. We evaluated WELL-DB against 15 industry peers in the Health Care Providers & Services industry. WELL-DB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, WELL-DB is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year WELL-DB has reported negative net income.
In the past year WELL-DB had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: WELL-DB reported negative net income in multiple years.
WELL-DB had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
WELL-DB has a worse Return On Assets (-6.37%) than 66.67% of its industry peers.
With a Return On Equity value of -15.57%, WELL-DB is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.37% | ||
| ROE | -15.57% | ||
| ROIC | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 39.21%, WELL-DB perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
WELL-DB's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for WELL-DB so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.21% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
2. Health
2.1 Basic Checks
WELL-DB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, WELL-DB has more shares outstanding
WELL-DB has more shares outstanding than it did 5 years ago.
WELL-DB has a better debt/assets ratio than last year.
2.2 Solvency
WELL-DB has an Altman-Z score of 13.32. This indicates that WELL-DB is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 13.32, WELL-DB belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
WELL-DB has a Debt/Equity ratio of 0.68. This is a neutral value indicating WELL-DB is somewhat dependend on debt financing.
WELL-DB has a Debt to Equity ratio of 0.68. This is in the better half of the industry: WELL-DB outperforms 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 13.32 |
ROIC/WACCN/A
WACC8.38%
2.3 Liquidity
WELL-DB has a Current Ratio of 0.93. This is a bad value and indicates that WELL-DB is not financially healthy enough and could expect problems in meeting its short term obligations.
WELL-DB's Current ratio of 0.93 is fine compared to the rest of the industry. WELL-DB outperforms 66.67% of its industry peers.
WELL-DB has a Quick Ratio of 0.93. This is a bad value and indicates that WELL-DB is not financially healthy enough and could expect problems in meeting its short term obligations.
WELL-DB has a Quick ratio of 0.92. This is in the better half of the industry: WELL-DB outperforms 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.92 |
3. Growth
3.1 Past
The earnings per share for WELL-DB have decreased strongly by -221.43% in the last year.
Looking at the last year, WELL-DB shows a very strong growth in Revenue. The Revenue has grown by 20.36%.
Measured over the past years, WELL-DB shows a very strong growth in Revenue. The Revenue has been growing by 94.78% on average per year.
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
3.2 Future
WELL-DB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.87% yearly.
Based on estimates for the next years, WELL-DB will show a quite strong growth in Revenue. The Revenue will grow by 16.34% on average per year.
EPS Next Y51.86%
EPS Next 2Y42.11%
EPS Next 3Y34.36%
EPS Next 5Y15.87%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y16.34%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for WELL-DB. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 332.08, which means the current valuation is very expensive for WELL-DB.
WELL-DB's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of WELL-DB to the average of the S&P500 Index (22.87), we can say WELL-DB is valued expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 332.08 |
4.2 Price Multiples
WELL-DB's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. WELL-DB is more expensive than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 384.34 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates WELL-DB does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as WELL-DB's earnings are expected to grow with 34.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.11%
EPS Next 3Y34.36%
5. Dividend
5.1 Amount
WELL-DB does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TSX:WELL-DB (10/28/2025, 7:00:00 PM)
100.6
+0.1 (+0.1%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners5.81%
Inst Owner ChangeN/A
Ins Owners22.59%
Ins Owner ChangeN/A
Market Cap25.54B
Revenue(TTM)1.10B
Net Income(TTM)-128618000
Analysts81
Price Target171.45 (70.43%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-368.63%
Min EPS beat(2)-696.08%
Max EPS beat(2)-41.18%
EPS beat(4)0
Avg EPS beat(4)-1069.61%
Min EPS beat(4)-3335.29%
Max EPS beat(4)-41.18%
EPS beat(8)2
Avg EPS beat(8)1698.56%
EPS beat(12)3
Avg EPS beat(12)1044.26%
EPS beat(16)3
Avg EPS beat(16)671.21%
Revenue beat(2)1
Avg Revenue beat(2)0.17%
Min Revenue beat(2)-1.25%
Max Revenue beat(2)1.59%
Revenue beat(4)1
Avg Revenue beat(4)-3.16%
Min Revenue beat(4)-12.61%
Max Revenue beat(4)1.59%
Revenue beat(8)4
Avg Revenue beat(8)-0.93%
Revenue beat(12)6
Avg Revenue beat(12)-0.37%
Revenue beat(16)10
Avg Revenue beat(16)0.69%
PT rev (1m)0%
PT rev (3m)6.8%
EPS NQ rev (1m)-5.09%
EPS NQ rev (3m)19.65%
EPS NY rev (1m)0%
EPS NY rev (3m)3.87%
Revenue NQ rev (1m)-0.18%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.83%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 332.08 | ||
| P/S | 23.31 | ||
| P/FCF | N/A | ||
| P/OCF | 5511.72 | ||
| P/B | 30.91 | ||
| P/tB | N/A | ||
| EV/EBITDA | 384.34 |
EPS(TTM)-0.51
EYN/A
EPS(NY)0.3
Fwd EY0.3%
FCF(TTM)-0.07
FCFYN/A
OCF(TTM)0.02
OCFY0.02%
SpS4.32
BVpS3.25
TBVpS-2.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.37% | ||
| ROE | -15.57% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 39.21% | ||
| FCFM | N/A |
ROA(3y)0.64%
ROA(5y)-0.59%
ROE(3y)1.32%
ROE(5y)-0.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.09%
GM growth 5Y3.31%
F-Score2
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.68 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 8.34 | ||
| Cap/Depr | 25.5% | ||
| Cap/Sales | 1.94% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 6.83% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.93 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 13.32 |
F-Score2
WACC8.38%
ROIC/WACCN/A
Cap/Depr(3y)15.79%
Cap/Depr(5y)16.17%
Cap/Sales(3y)1.31%
Cap/Sales(5y)1.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-221.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-90.7%
EPS Next Y51.86%
EPS Next 2Y42.11%
EPS Next 3Y34.36%
EPS Next 5Y15.87%
Revenue 1Y (TTM)20.36%
Revenue growth 3Y44.9%
Revenue growth 5Y94.78%
Sales Q2Q%46.69%
Revenue Next Year43.56%
Revenue Next 2Y25.75%
Revenue Next 3Y19.49%
Revenue Next 5Y16.34%
EBIT growth 1Y-144.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year286.51%
EBIT Next 3Y64.16%
EBIT Next 5Y42.51%
FCF growth 1Y-124.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-93.87%
OCF growth 3Y-22.85%
OCF growth 5YN/A
WELL HEALTH TECHNOLOGIES / WELL-DB.CA FAQ
What does WELL-DB do?
WELL Health Technologies Corp. operates as digital healthcare company, which engages in owning and operating a portfolio of primary healthcare facilities. The company is headquartered in Vancouver, British Columbia and currently employs 3,200 full-time employees. The company went IPO on 2012-12-17. Its healthcare and digital platform includes front and back-office management software applications that help physicians. Its business units include Canadian Patient Services, WELL Health USA Patient and Provider Services, and SaaS and Technology Services. The Canadian Patient Services segment provides primary care and allied health clinic operations in Canada and specialty care and accredited diagnostic health services from WDC. The WELL Health USA Patient and Provider Services segment includes U.S. primary care telehealth operations from Circle Medical; U.S. primary care operations from WISP; specialized care gastroenterology anesthesia services, and specialized medical recruitment and staffing services. The SaaS and Technology Services segment includes aggregation of electronic medical records, billing and revenue cycle management solutions, digital applications, and cybersecurity operating segments.
What is the current price of WELL-DB stock?
The current stock price of WELL-DB.CA is 100.6 CAD. The price increased by 0.1% in the last trading session.
How is the ChartMill rating for WELL HEALTH TECHNOLOGIES?
WELL-DB.CA has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is WELL HEALTH TECHNOLOGIES (WELL-DB.CA) stock traded?
WELL-DB.CA stock is listed on the Toronto Stock Exchange exchange.